Kazia therapeutics (kzia): deep dive into childhood brain cancer

London, uk / accesswire / may 26, 2022 / in light of the positive newsflow from kazia's efforts in addressing adult brain cancer, management is leveraging its niche expertise and experience to address a complex and untapped segment, childhood brain cancer. due to the challenges in addressing this unmet need, including significant hurdles in enrolling patients for a clinical trial, there is a vacuum of options for those served with this diagnosis.
KZIA Ratings Summary
KZIA Quant Ranking